Invest now

Rubicon Research share price

High risk
  • 50%Low risk
  • 50%Moderate risk
  • 50%Balanced risk
  • 50%High risk
  • 50%Extreme risk
  • 1,845.00(3.04%)
    September 11, 2026 15:29:59 PM IST
    • NSE
    • BSE
  • Vol : 269.36 K (NSE + BSE)
    Last 20 day avg : 1.16 M
Rubicon Research is trading 3.04% upper at Rs 1,845.00 as compared to its last closing price. Rubicon Research has been trading in the price range of 1,848.00 & 1,758.80. Rubicon Research has given 162.95% in this year & 0.81% in the last 5 days. Rubicon Research has TTM P/E ratio 79.09 as compared to the sector P/E of 37.04.The company posted a net profit of 84.78 Crores in its last quarter.Listed peers of Rubicon Research include Sun Pharmaceutical Industries (-1.18%), Divi's Laboratories (-0.84%), Torrent Pharmaceuticals (0.95%).The Mutual Fund holding in Rubicon Research was at 7.23% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Rubicon Research was at 7.52% in 30 Jun 2026. The FII holding has decreased from the last quarter.
  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Loading...
Key Metrics

Updated on 13 Sep 2026, 11:42 AM IST

  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.24
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
1,758.80
Highest
1,848.00
52 week range
Lowest
571.00
Highest
1,896.15
Rubicon Research Peers
Return Comparison
Peers Comparison
Names
Price%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
1,842.00-1.184,41,947.0938.405.550.830.47
Divi's Laboratories
9,326.00-0.842,47,576.0073.3211.480.410.03
Torrent Pharmaceuticals
4,975.000.951,89,226.2472.7319.220.80141.16
Cipla
1,365.00-1.091,10,272.6827.573.330.921.11
Zydus Lifesciences
1,119.500.131,11,670.5621.194.240.0914.22
Rubicon Research Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-08-14Quarterly Results
2026-05-29Audited Results & Final Dividend
2026-02-03Quarterly Results
2025-11-13Quarterly Results
About the company Rubicon Research
  • IndustryBiotechnology & Drugs
  • ISININE506V01022
  • BSE Code544578
  • NSE CodeRUBICON
Rubicon Research Ltd is an India-based pharmaceutical formulations company, which is focused on research and development, with a portfolio of specialty products and drug-device combination products targeting regulated markets, and particularly the United States. Its portfolio spans multiple dosage forms, including oral solids, oral liquids, nasal, and topical. Its technologies include RubiReten and RubiSRL. Its services include intellectual property evaluation and product design, formulation research development, analytical research development, technology transfer, dossier compilation and regulatory support, and clinical trials supplies. Its products are spread across many therapeutic areas, such as Analgesics/Pain Management, CVS, CNS, Hypokalemia, Skeletal Muscle Relaxants, NRT, Gastrointestinal, Metabolic, Immunosuppressant, and others. Others include Antipyretic, Hormonal Products, Diuretic, Antimuscarinics, Oral Rehydration Therapy, Over the Counter products, and Respiratory.
  • Management Info
  • Parag SanchetiChief Executive Officer, Executive Director
  • Nitin JajodiaChief Financial Officer
  • Deepashree TanksaleCompliance Officer, Company Secretary
  • Pratibha PilgaonkarManaging Director, Executive Director
Rubicon Research Share Price FAQs

Rubicon Research is trading at 1845.00 as on Fri Sep 11 2026 09:59:59. This is 3.04% upper as compared to its previous closing price of 1790.55.

The market capitalization of Rubicon Research is 30502.31 Cr as on Fri Sep 11 2026 09:59:59.

The 52 wk high for Rubicon Research is 1896.15 whereas the 52 wk low is 571.00

Rubicon Research can be analyzed on the following key metrics -

  • TTM P/E: 79.09
  • Sector P/E: 37.04
  • Dividend Yield: 0.00%
  • D/E ratio: -

Rubicon Research reported a net profit of 246.73 Cr in 2026.

The Mutual Fund Shareholding was 7.23% at the end of 30 Jun 2026.